Want to see WOK full AI Analyst Report?
WOK Stock Chart & Stats
$2.10
--
Market closed
$2.10
--
Day’s Range― - ―
52-Week Range$1.78 - $930,000.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)33.96M
Market Cap
$4.88M
Enterprise Value$2.36M
Total Cash (Recent Filing)$4.09M
Total Debt (Recent Filing)$6.45M
Price to Earnings (P/E)―
Beta0.91
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.58
Shares Outstanding2,416,538
10 Day Avg. Volume36,631,792
30 Day Avg. Volume33,957,643
Financial Highlights & Ratios
PEG Ratio-54.59
Price to Book (P/B)1.18K
Price to Sales (P/S)2203.94
P/FCF Ratio4.42K
Enterprise Value/Market Cap0.48
Enterprise Value/Revenue0.24
Enterprise Value/Gross Profit1.01
Enterprise Value/Ebitda-1.69
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Leverage / Balance Sheet HealthLower debt-to-equity materially reduces balance-sheet risk and interest burden, giving the company more financial flexibility. Over the next 2–6 months this supports capacity to fund operations, invest selectively or withstand revenue headwinds without immediate refinancing pressure.
Rebounded Operating And Free Cash FlowA return to positive operating and free cash flow signals improved cash generation and liquidity convertibility. This strengthens the company's ability to fund working capital, non-dilutive investment, or de-risk near-term funding needs, although consistency remains a monitoring point.
Established Capacity To Raise Significant CapitalAccess to a $200M equity sales agreement provides a durable financing option to support growth, R&D, or balance-sheet repair. Over months this enhances strategic optionality and liquidity buffers, enabling management to execute plans without immediate cash constraints.
Bears Say
Contracting Revenue And Persistent LossesDeclining top line and negative margins indicate structural demand or competitive challenges that limit profitable scale. Persisting revenue contraction reduces ability to leverage fixed costs, undermines long-term return on capital, and constrains reinvestment without clear demand recovery.
Insider Consolidation Of Voting ControlA single insider controlling majority voting power can entrench leadership and prioritize insider objectives. Over the medium term this raises governance risk for minority holders, may enable related-party decisions or limit oversight, and can affect strategic alignment with outside investors.
Broad Capital-restructuring Powers And Dilution RiskProposed sweeping capital changes give the board broad discretion to reshape the capital base, lowering par value and enabling substantial issuance. Structurally this increases dilution risk, can weaken shareholder economic rights, and may be used to raise capital on terms unfavorable to existing holders.
WORK Medical Technology Group LTD News
WOK FAQ
What was WORK Medical Technology Group LTD’s price range in the past 12 months?
WORK Medical Technology Group LTD lowest stock price was $1.78 and its highest was $930000.00 in the past 12 months.
What is WORK Medical Technology Group LTD’s market cap?
WORK Medical Technology Group LTD’s market cap is $4.88M.
When is WORK Medical Technology Group LTD’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were WORK Medical Technology Group LTD’s earnings last quarter?
Currently, no data Available
Is WORK Medical Technology Group LTD overvalued?
According to Wall Street analysts WORK Medical Technology Group LTD’s price is currently Overvalued.
Does WORK Medical Technology Group LTD pay dividends?
WORK Medical Technology Group LTD does not currently pay dividends.
What is WORK Medical Technology Group LTD’s EPS estimate?
WORK Medical Technology Group LTD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does WORK Medical Technology Group LTD have?
WORK Medical Technology Group LTD has 2,416,538 shares outstanding.
What happened to WORK Medical Technology Group LTD’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of WORK Medical Technology Group LTD?
Currently, no hedge funds are holding shares in WOK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
WORK Medical Technology Group LTD
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---